IO Biotech puts down roots in USA and hires new CSO
The Danish firm, which raised DKK 944m in January, is establishing a new R&D department in the US before a possible public offering.
BY ALBERT RØNNING-ANDERSEN, TRANSLATED BY CATHERINE BRETT
In a press release, IO Biotech has revealed that it is setting up a new center for research and development in the US.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Cancer firm Adcendo raises EUR 51m
For subscribers
